DANIEL LEE DELO MD NPI 1114128618

NPI Information

  • NPI: 1114128618
  • Provider Name: DANIEL LEE DELO, MD
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1710 S 17TH ST
    WILMINGTON, NC
    ZIP 28401
  • Phone: (910) 762-1182

Map and Directions

Get Directions

NPI Details

Daniel Lee Delo, MD is a rheumatology internal medicine in Wilmington, NC with 22 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Daniel Lee Delo, MD NPI is 1114128618. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2004

The provider's business location address is:

1710 S 17TH ST
WILMINGTON, NC
ZIP 28401-442
Phone: (910) 762-1182
Fax: (910) 762-1291

The NPI 1114128618 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Blood creatinine level (HCPCS:82565)
  • Liver function blood test panel (HCPCS:80076)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete ultrasound scan of joint (HCPCS:76881)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Tuberculosis test, enumeration of t-cells (HCPCS:86481)
  • Vitamin d-3 level (HCPCS:82306)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Measurement of complement function (immune system proteins) (HCPCS:86161)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Uric acid level, blood (HCPCS:84550)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Phosphate level (HCPCS:84100)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Rheumatoid factor level (HCPCS:86431)
  • Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Calcium level, total (HCPCS:82310)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • X-ray of foot, minimum of 3 views (HCPCS:73630)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • X-ray of knee, 3 views (HCPCS:73562)
  • X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • X-ray of upper spine, 4-5 views (HCPCS:72050)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 5/30/2007 and was last updated on 7/21/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology2007-00475NORTH CAROLINAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.